Ikarian Capital’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-337,636
| Closed | -$1.01M | – | 100 |
|
|
2023
Q4 | $1.01M | Sell |
337,636
-1,400,000
| -81% | -$4.19M | 0.09% | 51 |
|
|
2023
Q3 | $1.7M | Buy |
1,737,636
+32,031
| +2% | +$31.4K | 0.2% | 33 |
|
|
2023
Q2 | $2.37M | Buy |
1,705,605
+350,000
| +26% | +$487K | 0.38% | 29 |
|
|
2023
Q1 | $2.16M | Sell |
1,355,605
-535,542
| -28% | -$852K | 0.49% | 35 |
|
|
2022
Q4 | $11.8M | Sell |
1,891,147
-240,000
| -11% | -$1.5M | 2.84% | 5 |
|
|
2022
Q3 | $14.3M | Buy |
2,131,147
+76,545
| +4% | +$513K | 2.85% | 2 |
|
|
2022
Q2 | $13.1M | Buy |
+2,054,602
| New | +$13.1M | 2.38% | 2 |
|